Pfizer ends Covid-19 trial with 95% efficacy, to seek emergency-use authorization

Pfizer Inc said on Wednesday that final results from the late-stage trial of its Covid-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency US authorization within days.

Keywords
Τυχαία Θέματα